Wednesday, September 4
Optimizing Metabolomics Technologies for Development of Microbial-Based Cosmetics &
Therapeutics for Skin
As advanced sequencing technologies have become more accessible, this has facilitated our understanding in ‘who’s there’ in the skin microbiome. However, it has become even more important that we understand which microbes are functionally useful in maintaining a healthy skin ecology and how this can inform our selection, isolation and culturing of microbes for product development. This workshop will give you the opportunity to understand:
• Where are we now with metabolomics technologies and analysis?
• How are we analyzing cosmetic and therapeutic products using metabolomics and other –omics approaches?
• What are the applications and limitations of these approaches, and how can we translate data into knowledge?
Assistant Project Scientist, Dorrenstein's Lab
UC San Diego
UC San Diego
A 360 Panorama of Commercialization for Microbial-Based Therapeutic Products
As microbial-based products begin to occupy a greater market share, understanding the best way to get these products to market and communicating their value to consumers will be crucial to ensuring
their success. The workshop will give you the opportunity to understand:
• Microbial-based product development through a commercial lens: How do you access a market with no single entry point and what are the barriers to entry?
• What does it mean to have a robust IP portfolio and how will IP filing for microbial-based therapeutics change in the future?
• How to reach end-users through positioning and differentiation of microbial-based therapeutics in order to stay competitive?
Principal, Co-Founder & CSO
CEO, Principal & Co-Founder
Partner – Intellectual Property
Wilson Sonsini Goodrich & Rosati